Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

warrenswil

(60 posts)
Mon Nov 4, 2013, 12:01 PM Nov 2013

Healthcare reform’s most unlikely winner: India

While the media and Republicans seem obsessed with the problems related to the rollout of healthcare reform, a few entities are rejoicing.
They are about to become very rich – or, on some cases, even richer.
The most surprising one of all, however, is not even in America. We analyzed it today in:
India’s pharmaceutical industry eyes vast expansion
India and its generic drug makers are gearing up for a massive expansion as millions of new prescriptions are written for generic drugs covered under the new insurance policies.
This was reported during the height of the government shutdown on Oct. 4 by the BBC in
'Obamacare' boost to Indian pharmaceutical industry
However, before you rush out to buy stock in one of the Indian pharmaceutical companies that stands to benefit, better do some homework.
The industry is rife with problems, and it’s not difficult to find examples.
It would pay to do a great deal of research on the topic before ingesting prescribed medications imported from India.
And it could cost an arm and a leg if you rush headlong into investing in a drug maker with a dubious track record.



1 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Healthcare reform’s most unlikely winner: India (Original Post) warrenswil Nov 2013 OP
The postage used to cost more than the meds. What was $10 a pill here, was around 15 cents before libdem4life Nov 2013 #1
 

libdem4life

(13,877 posts)
1. The postage used to cost more than the meds. What was $10 a pill here, was around 15 cents before
Mon Nov 4, 2013, 06:18 PM
Nov 2013

generic approval. But as an investor? I'd be wary. Used to be similar in Canada, but long ago Big Pharma shut them down ... at least their lower prices ... with legal threats, same as Mexico.

Latest Discussions»Retired Forums»2016 Postmortem»Healthcare reform’s most ...